Introduction 1 0 0 neighboring peptide stems) (10, 11); while these LD-crosslinks increase stalk PG resistance to 1 0 1 lysozyme-mediated degradation (11), abrogation of LD-transpeptidation has no effect on stalk 1 0 2 elongation (10, 11). have successfully identified a number of stalk-or stalk-pole localized proteins, including: PbpC 1 0 5 (12), BacA (12), StpX (13), BamE (14) , and DipM (15). The deletion of these genes shortens, 1 0 6 6 but does not eliminate, stalks in low-phosphate conditions. The difficulty in isolating a stalk-less 1 0 7 C. crescentus strain implies that either: 1) stalk synthesis is an essential physiological process, 2) 1 0 8 the synthesis enzymes have a secondary essential function and can therefore not be isolated by 1 0 9 transposon mutagenesis, or 3) there is redundancy in the stalk synthesis pathway. In this report, we used chemical mutagenesis to introduce single-nucleotide 1 1 1 polymorphisms (SNPs) and screened for mutants with stalk elongation defects. We isolated a 1 1 2 strain with mutations in ccna_03732 (manA), a phosphomannose isomerase, that affected sugar-1 1 3 phosphate metabolism, cellular envelope biosynthesis, and entry into stationary phase. These suggesting that cellular metabolism regulates stalk elongation independently of phosphate 1 1 6 starvation. Genetic screens for phenotypes of interest are commonly performed by transposon 1 2 2 mutagenesis. While this approach is quite powerful and allows for easy mapping of transposon 1 2 3 insertions, it has the drawback that insertions in essential genes are highly unlikely since these 1 2 4 mutants tend to be total loss-of-function and lethal. As an alternative approach, we used chemical 1 2 5 mutagenesis to introduce SNPs into the C. crescentus genome and devised a screening 1 2 6 methodology to isolate stalk-deficient mutants (see Materials and Methods). Briefly, C. crescentus cells grown in Hutner-Imidazole-Glucose-Glutamate media (HIGG) containing 1 mM 1 2 8 phosphate (high phosphate) were treated with 1-methyl-3-nitro-1-nitrosoguanidine (NTG) to 1 2 9 induce DNA mutations. The cells were washed and resuspended in HIGG-1 µM phosphate (low 1 3 0 phosphate) to induce stalk elongation. To separate cells with stalk deficiencies, we reasoned that near the bottom of the gradient; therefore, we hypothesized that stalk-deficient cells would move individual colonies were grown in HIGG-1 µM phosphate and visually screened for stalk-1 3 7 phenotypes. One particular isolate, designated Stalk-Deficient-Mutant 1 (SDM1) had very short 1 3 8 stalks compared to wild-type when grown in low phosphate ( Fig. 1A) . Whole-genome sequencing of the SDM1 strain yielded 79 potential SNPs. To identify the 1 4 3 causative mutation for the stalk elongation phenotype, we performed complementation assays 1 4 4 using a C. crescentus genomic cosmid library (16). Two cosmids, 2G12 and 2H1, were able to 1 4 5 restore stalk elongation in low phosphate (Fig. 1A) . These cosmids had an overlapping region of 1 4 6 approximately 10 kb which contained 10 genes. Based on our sequencing data, of these 10 genes, 1 4 7 only ccna_03732 had any SNPs (Fig. 1B) . The two missense mutations in ccna_03732 resulted 1 4 8 in amino acid substitutions A23T and G339N. To confirm that ccna_03732 was necessary for the 1 4 9 stalk elongation phenotype, we exogenously expressed wild-type ccna_03732 in the SDM1 1 5 0 strain and observed recovery of stalk synthesis (Fig. 1C ). Introduction of the two missense 1 5 1 mutations into the ccna_03732 chromosomal locus of wild-type C. crescentus phenocopied the 1 5 2 SDM1 stalk deficiency, thereby demonstrating that these mutations were sufficient to inhibit 1 5 3 stalk elongation (Fig. 1C ). To determine which SNP was responsible for the SDM1 phenotype, had no significant effect on stalk elongation whereas the G339N mutation only partially 1 5 6 recapitulated the elongation defect seen in SDM1 ( Fig. 1C-D) . Therefore, we conclude that the 1 5 7 SDM1 stalk-elongation phenotype required both SNPs. The ccna_03732 gene is predicted to be 1 5 8 essential (17) and we were unable to generate a deletion of this gene using standard allelic 1 5 9 replacement methods, thereby demonstrating the power of chemical mutagenesis for phenotypic ManA); therefore, we tested whether any of these genes could complement the CCNA_03732 1 7 4 mutation. Only expression of ManA was able to rescue stalk elongation ( Fig. 2A) ; therefore, we 1 7 5 will refer to CCNA_03732 as ManA. ManA is a phosphomannose isomerase (PMI) which to wild-type ( Fig. 2A ), this may because E. coli ManA is a type-I PMI whereas C. crescentus 1 7 9
ManA appears to be a type-III enzyme (21). The three subfamilies of PMIs have similar To investigate the mechanism of the ccna_03732 A23T/G339N (referred to as manA * ) 1 8 2 mutations, we performed a suppressor screen to isolate mutants which regained stalk elongation type and manA * strains demonstrated that wild-type cells maintained a 1:1 ratio in both high and 1 9 0 low phosphate whereas the ratio rises to 2:1 for manA * cells in low phosphate ( Fig. 2E ). These 1 9 1 data suggest that in low phosphate, ManA * cannot efficiently convert F6P to M6P. Mapping the 1 9 2 A23T and G339N mutations onto a homology model of ManA (produced using Phyre 2.0 (23) 1 9 3 based on PDB structure 1FP3 (24)) showed that the mutations are positioned near one another 1 9 4 yet distant from the predicted protein active site ( Fig. 2F ) (19) making it difficult to propose a 1 9 5 mechanism for reduced ManA activity. for PG and core lipopolysaccharide (LPS) synthesis. M6P, which is metabolized to GDP-2 0 2 mannose, serves as a precursor for LPS O-antigen and exopolysaccharide (EPS) synthesis (26). manA * cells did not reveal any gross changes in PG composition (Fig. 3C ). Lastly, production of 2 0 9 1 1 EPS was assessed by the presence of a mucoid phenotype when grown on agar plates 2 1 0 supplemented with 3% sucrose; wild-type cells producing EPS were mucoid while manA * cells 2 1 1 were dull in appearance ( Fig. 3D ). Non-EPS producing strains (CB15 and NA1000 Δ MGE) were 2 1 2 included as controls (26). Together, these findings showed that F6P-dependent metabolism was 2 1 3 unaffected in the manA * strain, whereas M6P-dependent processes were inhibited. This is 2 1 4 consistent with the ManA * mutant being an enzymatic hypomorph leading to an increased 2 1 5 F6P:M6P ratio (Fig. 2C, E) . To determine whether these changes in cellular envelope were the 2 1 6 cause of the stalk elongation defect, stalk lengths were measured in NA1000 strains lacking not to the same degree as the manA * strain (Fig. 3E ). While the partial effect of Tn5::wbqP on 2 2 0 stalk length suggests that O-antigen synthesis plays a role in stalk elongation, an alternative 2 2 1 explanation is that the inhibition of this pathway alters the flux through connected metabolic 2 2 2 pathways leading to stalk elongation defects. ManA regulates entry into stationary phase 2 2 5
Since F6P and M6P feed into a variety of metabolic pathways, we performed 2 2 6 metabolomic analyses of wild-type and manA * cells grown in low-phosphate to assess global 2 2 7 changes in cellular metabolism. As expected, wild-type cells had higher levels of M6P as 2 2 8 compared to manA * cells; additionally, we found higher levels of TCA cycle intermediates in wild-type cells (Fig. 4A ). Accumulation of TCA cycle intermediates is consistent with bacteria 2 3 0 entering stationary phase (29, 30), therefore, we performed long term growth curves to assess 1 2 at OD 660 =1.8; by contrast, manA * cells continued to divide to OD 660 =2.5, suggesting that they 2 3 3 failed to enter stationary phase (Fig. 4B ). As observed with regards to stalk elongation, 2 3 4 exogenous expression of manA in the mutant background restored wild-type growth kinetics 2 3 5 ( Fig. 4B ). Consistent with their increased proliferation, manA * cells had lower expression of 2 3 6 known stationary-phase genes cspD, katG, and spdR (31) following 48 h of culture in low-2 3 7 phosphate media ( Fig. 4C) and deletion of the stationary-phase response regulator spdR inhibited 2 3 8 stalk elongation (Fig. 4D ). overproduction of ppGpp resulted in a significant increase in stalk length (Fig. 4E ). mechanism is not well understood. Perturbation of genes associated with peptidoglycan synthesis 1 4 Δ pmi promastigotes were shorter and rounder than wild-type (37). composition of the PG was not affected in the manA * strain (Fig. 3C) ; thus, another mechanism 2 7 6 is required to explain the stalk elongation phenotype. While the manA * mutations affected LPS O-antigen and EPS production, these envelope perturbations were not solely responsible for the 2 7 8 mutant cell defect ( Fig. 3E ).
7 9
In addition to interfering with cellular envelope biosynthesis, the metabolic imbalance 2 8 0 produced by the manA * mutations prevents stationary-phase entry of C. crescentus (Fig. 4A-C) . The accumulation of sugar-phosphates triggers a variety of bacterial stress responses. In B. Genomic DNA was isolated from NA1000 and SDM1, barcoded sequencing libraries were (New England Biolabs), and templated using the Ion PI Hi-Q Chef kit (Thermo Fisher). The 3 2 7 libraries were sequenced on an Ion Proton system (Thermo Fisher) (NA1000: 2,148,749 reads, 3 2 8 mean read length=132 bp, mean sequencing depth=70X; SDM1: 1,976,601 reads, mean read 3 2 9 length=132 bp, mean sequencing depth=64X). Reads were mapped to the NA1000 genomic We thank Lucy Shapiro (Stanford University) and Christine Jacobs-Wagner (Yale University) for providing reagents and Xiaoyang Su and the metabolomics core facility at the Cancer phosphate derepressed the glcR-phoC operon from repression by GlcR. J Bacteriol 201. crescentus. J Bacteriol 135:1141-5. both ccna_03732 SNPs into NA1000 was sufficient to produce the stalk-elongation defect, 5 7 6
whereas each individual SNP had either no effect (A23T) or a partial effect (G339N). Scale bar: 
